$181.73
-4.21 (-2.26%)
At Close: Jun 02, 2026
Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus
12:00am, Friday, 04'th Jan 2019Why ultra-low fees can be a serious red flag for unwary ETF investors
12:59pm, Monday, 29'th Oct 2018
Investors must be wary of hidden fees that lurk with ETFs, even though fund fees are on a steady decline. Experts suggest investors follow a handful of rules to help navigate the marketplace.
Sign In
Buy BBH